Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents
General Info
Time period covered
January, 2001 - December, 2009
Data type
Scientific literature
Keywords
Citation
Journal
J Clin Pharm Ther
Pages
41-7
Publication year
2013
Suggested citation
Gaultney JG, Franken MG, Tan SS, Redekop WK, Huijgens PC, Sonneveld P, Uyl-de Groot CA. Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents. J Clin Pharm Ther. 2013; 38(1): 41-7.